CAMP
CAMP4 Therapeutics Corporation
There isn't enough reported data to score CAMP yet.
NVO
Novo Nordisk A/S
NVO's fundamentals are mixed: it turned 15% of its revenue into free cash flow, but its operating margin fell 3 points to 43%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
CAMP Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Under pressure | |
| Weak |
CAMP's profitability, cash flow and balance sheet are currently under pressure. There isn't enough data to rate its revenue.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
CAMP PE Valuation
CAMP has no meaningful PE right now: it lost money over the past year.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.
CAMP Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect CAMP's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NVO's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
CAMP Earnings Per Share
CAMP lost $2.13 per share over the past year, a bigger loss than the year before.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO has the edge over CAMP in the latest year-over-year earnings comparison.
CAMP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.9M | +139% |
| Q2 2026 | $1.8M | +19% |
| Q1 2026 | $1.3M | +51% |
| Q3 2023 | $350K | -100% |
| Q2 2023 | $70.9M | +9.5% |
| Q1 2023 | $78.5M | +15% |
| Q4 2022 | $78.9M | +15% |
| Q3 2022 | $72.8M | -7.8% |
CAMP's revenue is recovering but still below its 2020 peak: $2M last quarter, up 139% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -739% | +978 points |
| Q2 2026 | -752% | +118 points |
| Q1 2026 | -1010% | +517 points |
| Q4 2025 | -3671% | N/A |
| Q3 2025 | -1717% | N/A |
| Q2 2025 | -870% | N/A |
| Q1 2025 | -1527% | N/A |
| Q3 2023 | -3525% | -3518 points |
CAMP's operating margin was −739% last quarter, up 978 points from the same quarter a year ago.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO has the edge over CAMP on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO has the edge over CAMP on profitability, with a higher operating margin.
CAMP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$8.9M | +$2.3M |
| Q2 2026 | -$12.8M | -$2.5M |
| Q1 2026 | -$11M | +$3.6M |
| Q4 2025 | $6.3M | +$17.8M |
| Q2 2025 | -$10.3M | +$3.3M |
| Q1 2025 | -$14.6M | -$3.4M |
| Q4 2024 | -$11.6M | +$475K |
| Q2 2024 | -$13.6M | -$10.5M |
CAMP has burned cash in most quarters: −$26M over the past year, against −$48M the year before.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO has the edge over CAMP on cash generation, producing positive trailing cash flow while its opponent burns cash.
CAMP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2021 | 25.3x | High |
| Q2 2021 | 14.1x | High |
| Q1 2021 | 8.2x | High |
| Q4 2020 | 15.9x | High |
| Q3 2020 | 16.1x | High |
| Q2 2020 | 9.9x | High |
| Q1 2020 | 13.2x | High |
CAMP's net debt is more than 20 years of its operating earnings (EBITDA), up from 16 years a year ago.
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO's net debt is less than a year of its operating earnings (EBITDA).
CAMP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.5 | Neutral |
| Stochastic | 35.4 | Neutral |
CAMP's weekly RSI is 51 (neutral) and its Stochastic is 35 (neutral).
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
CAMP PE vs Healthcare Sector
CAMP has no meaningful PE right now: it lost money over the past year.
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO is trading at 10x earnings, a 60% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
CAMP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.78 | 8.2% above |
| 20 week MA | $4.03 | 1.5% above |
| 50 week MA | $4.39 | 6.8% below |
| 100 week MA | $3.75 | 9.1% above |
CAMP has stronger trend alignment. CAMP is above 3 of 4 weekly averages versus NVO above 1 of 5.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 50% below its 200-week average.
CAMP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $10.7 | $5.43 | -49% |
| 2025 | $5.43 | $5.96 | +9.8% |
| 2026 YTD | $5.96 | $4.09 | -31% |
CAMP has finished lower in one of the last two years. It's down 31% so far in 2026.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has the edge over CAMP on returns for 2026, with the stronger performance.